Benefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
Updated analysis showed longer progression-free and overall survival for patients with advanced renal cell carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.